# GlaxoSmithKline Biologicals – FDA Inspection, Mar 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/70a6a284-2119-4f02-9b73-85f02c66c432
Source feed: FDA_Inspections

> FDA inspection 1232702 of GlaxoSmithKline Biologicals, March 12, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232702
- Company Name: GlaxoSmithKline Biologicals
- Inspection Date: 2024-03-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1242355 - 2024-06-04
- [FDA Inspection 1179634 - 2022-09-13](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/b7981ae6-29ac-4d33-bb97-b46c00e4538f)
- [FDA Inspection 1074672 - 2018-11-13](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/b7cb345e-7492-4016-bfb2-29932766b0e4)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/latorie-s-jones/086d0897-7d63-4fa8-bdce-f1d17885abd7)
- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
